Ruxolitinib Phosphate in Reducing Fatigue in Patients With Chronic Lymphocytic Leukemia

NCT02131584 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukemia

Interventions

OTHER: Questionnaire Administration
DRUG: Ruxolitinib Phosphate

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]